HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE IN THE TREATMENT OF MULTIPLE-SCLEROSIS - CLINICAL-IMMUNOLOGICAL CORRELATIONS

被引：170

作者：

DURELLI, L

COCITO, D

RICCIO, A

BARILE, C

BERGAMASCO, B

BAGGIO, GF

PERLA, F

DELSEDIME, M

GUSMAROLI, G

BERGAMINI, L

机构：

来源：

NEUROLOGY | 1986年 / 36卷 / 02期

关键词：

D O I：

10.1212/WNL.36.2.238

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：238 / 243

页数：6

共 16 条

[1]

ABBRUZZESE G, 1983, ITAL J NEUROL SCI, V2, P169

[2]

BALOW JE, 1975, J IMMUNOL, V114, P1072

[3]

BAUMHEFNER RW, 1981, NEUROLOGY, V31, P147

[4] DESIGN OF CLINICAL STUDIES TO ASSESS THERAPEUTIC EFFICACY IN MULTIPLE-SCLEROSIS [J].

BROWN, JR ;

BEEBE, GW ;

KURTZKE, JF ;

LOEWENSON, RB ;

SILBERBERG, DH ;

TOURTELLOTTE, WW .

NEUROLOGY, 1979, 29 (09) :3-23

[5] TREATMENT OF ACUTE EXACERBATIONS OF MULTIPLE-SCLEROSIS WITH INTRAVENOUS METHYLPREDNISOLONE [J].

BUCKLEY, C ;

KENNARD, C ;

SWASH, M .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1982, 45 (02) :179-180

[6] POSSIBLE BENEFICIAL EFFECT OF HIGH-DOSE INTRAVENOUS STEROID-THERAPY IN ACUTE DEMYELINATING DISEASE AND TRANSVERSE MYELITIS [J].

DOWLING, PC ;

BOSCH, VV ;

COOK, SD .

NEUROLOGY, 1980, 30 (07) :33-36

[7] GLUCOCORTICOSTEROID THERAPY - MECHANISMS OF ACTION AND CLINICAL CONSIDERATIONS [J].

FAUCI, AS ;

DALE, DC ;

BALOW, JE .

ANNALS OF INTERNAL MEDICINE, 1976, 84 (03) :304-315

[8]

KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444

[9] IMMUNOGLOBULIN ABNORMALITIES IN MULTIPLE-SCLEROSIS - RELATION TO CLINICAL PARAMETERS - EXACERBATIONS AND REMISSIONS [J].

OLSSON, J ;

LINK, H .

ARCHIVES OF NEUROLOGY, 1973, 28 (06) :392-399

[10] NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS - GUIDELINES FOR RESEARCH PROTOCOLS [J].

POSER, CM ;

PATY, DW ;

SCHEINBERG, L ;

MCDONALD, WI ;

DAVIS, FA ;

EBERS, GC ;

JOHNSON, KP ;

SIBLEY, WA ;

SILBERBERG, DH ;

TOURTELLOTTE, WW .

ANNALS OF NEUROLOGY, 1983, 13 (03) :227-231

← 1 2 →